论文部分内容阅读
本刊讯 据国家药监局南方医药经济研究所提供的信息,同仁堂(集团)有限责任公司董事长殷顺海日前向外界透露,老字号企业同仁堂目前已经制定未来8年的发展规划,核心内容是通过改造10种传统名药,全面提升我国中药产业的市场竞争力。 殷顺海说,目前,我国的中药产业面临着一定的困境:首先是那些不可再生的中
According to the information provided by the SFDA Southern Medical Economics Institute, Yin Shunhai, chairman of Tong Ren Tang (Group) Co., Ltd., disclosed to the outside world that the old company Tong Ren Tang has now formulated a development plan for the next eight years. The core content is through transformation 10 kinds of traditional medicine, to enhance China’s traditional Chinese medicine industry’s market competitiveness. Yin Shunhai said that at present, China’s traditional Chinese medicine industry is facing a certain predicament: first, those who are not renewable in